WISeKey International Holding Ltd Announces Agenda Items to be Approved by Shareholders at its 2024 Annual General Meeting
May 28, 2024 01:00 ET
|
Wisekey International Holding Ltd.
Zug, Switzerland, May 28, 2024 – Ad-Hoc announcement pursuant to Art. 53 of SIX Listing Rules – WISeKey International Holding Ltd. (“WISeKey” or the “Company”) (SIX: WIHN, NASDAQ: WKEY), a leading...
WISeKey begrüßt die Entscheidung der Eidgenossenschaft, bis 2026 eine eigene „Cloud“ einzurichten
May 28, 2024 01:00 ET
|
Wisekey International Holding Ltd.
Genf, Schweiz – 28. Mai 2024: WISeKey International Holding Ltd. („WISeKey“) (SIX: WIHN, NASDAQ: WKEY), ein weltweit führendes Unternehmen im Bereich Cybersicherheit, digitale Identität und Internet...
WISeKey Welcomes Confederation’s Decision to Establish the “Swiss Government Cloud” by 2026
May 28, 2024 01:00 ET
|
Wisekey International Holding Ltd.
WISeKey is at the forefront of leveraging Switzerland as a central hub for data storage, including utilizing mountain facilities to store cryptographic root keys (https://lnkd.in/eJEmFn96). ...
IZEA荣获三项Communicator大奖
May 27, 2024 21:00 ET
|
IZEA Worldwide, Inc.
美国佛罗里达州奥兰多, May 27, 2024 (GLOBE NEWSWIRE) -- IZEA Worldwide, Inc.（NASDAQ：IZEA），作为创作者经济的首要技术、数据和服务提供商，今天宣布在第30届Communicator Awards 中获得了三项荣誉。IZEA在与Sublue的合作项目荣获了“活动与系列品牌”类别的卓越奖。此外，IZEA与TECNO...
Mercer International Inc. Releases 2023 Sustainability Report
May 27, 2024 16:30 ET
|
Mercer International Inc.
NEW YORK, May 27, 2024 (GLOBE NEWSWIRE) -- Mercer International Inc. (“Mercer” or the “Company”) (Nasdaq: MERC) -- a global forest products company, today released its 2023 Sustainability Report....
Cellectis publiera ses résultats financiers du premier trimestre 2024 le 28 mai 2024
May 27, 2024 16:30 ET
|
Cellectis Inc.
NEW YORK, 27 mai 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa technologie pionnière d’édition du génome...
Cellectis to Report First Quarter 2024 Financial Results on May 28, 2024
May 27, 2024 16:30 ET
|
Cellectis Inc.
NEW YORK, May 27, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
JD.com to Hold Annual General Meeting on June 21, 2024
May 27, 2024 06:00 ET
|
JD.com, Inc.
BEIJING, May 27, 2024 (GLOBE NEWSWIRE) -- JD.com, Inc. (“JD.com” or the “Company”) (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and...
Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
May 25, 2024 09:40 ET
|
Vera Therapeutics
72-week data consistent with disease modification in IgAN, selected as a best-ranked abstract;Rapid and sustained improvements in hematuria over 36 weeks, with resolution in significantly greater...
Merus : publication d’un résumé sur l’association pétosemtamab + pembrolizumab dans le traitement de 1re ligne du CETC r/m lors de l’édition 2024 du congrès ASCO®
May 24, 2024 21:30 ET
|
Merus N.V.
- Taux de réponse de 60 % observé auprès de 10 patients évaluables - Profil d’innocuité favorable chez 26 patients recrutés à la date de clôture du résumé, sans aucune observation de...